Pathogenesis of Hematologic Malignancies
Pathogenesis of Hematologic Malignancies
Enrolling by invitation · NCT01728402 · Registry updated 2026-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pathogenesis of Hematologic Malignancies | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, acute leukemia, bone marrow disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome, myelodysplastic syndrome | Enrolling by invitation | Not stated | 2026-08-13 | NCT01728402 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| National Institutes of Health (NIH) | 667 |
| OHSU Knight Cancer Institute | 61 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| OHSU Knight Cancer Institute | Portland | United States | 69 |